Stroke Trial, Recruiting NCT06133179 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06133179
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who are currently hospitalised after having an ischemic stroke (a stroke caused by a blocked blood vessel) in a specific deep region of the brain supplied by the middle cerebral artery
  • People whose stroke can be seen on an MRI scan
  • People who are enrolled in the trial between 24 hours and 7 days after their stroke occurred
  • People whose skull has an area near the temple that allows ultrasound waves to pass through clearly enough to image the relevant blood vessels
  • People who have given their signed, informed, and written agreement to take part
  • People who are covered by the French social security system (excluding AME, a specific state medical aid program)

Who may not be able to join:

  • People who have had a stroke, or have a blocked artery, on the opposite side of the brain to the one being studied
  • People who have a medical reason they cannot receive contrast-enhanced Doppler ultrasound, such as having an abnormal connection between the right and left sides of the heart, or severely high blood pressure in the lungs
  • People who have a known allergy or sensitivity to SonoVue (a contrast agent used in ultrasound) or any of its ingredients, including sulfur hexafluoride
  • People with high blood pressure that is not currently under control
  • People with a serious breathing condition known as respiratory distress syndrome
  • People who are under a legal guardianship or curatorship arrangement
  • People who are pregnant or breastfeeding (confirmed by a blood test during hospitalisation)
  • People who have damaged or broken skin at the temple area where the ultrasound would be applied
  • People who have had a heart attack or have unstable heart disease in the 7 days before joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01.40.25.70.33

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 March 2024
Est. completion
1 February 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Describe the vascular mapping obtained by 3D transcranial ULM of patients with ischemic stroke in the territory of the middle cerebral artery and its perforators; Describe the vascular mapping obtained by 3D transcranial ULM of patients with ischemic stroke in the territory of the middle cerebral artery and its perforators; Describe the vascular mapping obtained by 3D transcranial ULM of patients with ischemic stroke in the territory of the middle cerebral artery and its perforators; Describe the vascular mapping obtained by 3D transcranial ULM of patients with ischemic stroke in the territory...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov